RHYTHM PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-49.3M | $-55.6M | $-52.9M | $-46.6M | $-49.5M | $-43.6M | $-32.3M | $-141.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $23.1M | — | — | $12.9M | — | — | $7.8M |
| Net Cash from Operating Activities | $-9.2M | $-44.2M | $-26.6M | $-23.3M | $-40.4M | $-25.2M | $-29.1M | $-40.7M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $57.1M | — | — | $24.8M | — | — | $30.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-5.4M | — | — | $32.5M | — | — | $4.2M |
| Net Change in Cash | — | $7.9M | — | — | $17.0M | — | — | $-6.5M |
| Free Cash Flow | — | — | — | — | — | — | — | — |